Skip to main content
. 2021 Mar 26;14:2203–2212. doi: 10.2147/OTT.S278029

Table 1.

Comparison of Clinicopathological Data Between dMMR and pMMR Colorectal Cancer

pMMR n=183 dMMR n=61 Total n=244 P value
Age
 >55 154 (84.2%) 41 (67.2%) 195 0.004*
 ≤55 29 (15.8%) 20 (32.8%) 49
Sex
 Male 113 (61.7%) 28 (45.9%) 141 0.030*
 Female 70 (38.3%) 33 (54.1%) 103
Location
 Left 47 (25.7%) 11 (18.0%) 58 0.000*
 Right 34 (18.6%) 39 (63.9%) 73
 Rectum 102 (55.7%) 11 (18.0%) 113
Diameter
 ≦5 cm 131 (71.6%) 27 (44.3%) 158 0.000*
 >5 cm 52 (28.4%) 34 (55.7%) 86
Lymphovascular invasion
 Absent 109 (59.6%) 42 (68.9%) 151 0.196
 Present 74 (40.4%) 19 (31.1%) 93
Extranodal extension
 Absent 160 (87.4%) 57 (93.4%) 217 0.195
 Present 23 (12.6%) 4 (6.6%) 27
T stage
 T1-3 143 (78.1%) 23 (37.7%) 166 0.000*
 T4 40 (21.9%) 38 (62.3%) 78
N stage
 N0 116 (63.4%) 44 (72.1%) 160 0.298
 N1 47 (25.7%) 14 (23.0%) 61
 N2 20 (10.9%) 3 (4.9%) 23
TNM stage
 I 23 (12.6%) 9 (14.8%) 32 0.501
 II 94 (51.4%) 35 (57.4%) 129
 III 66 (36.1%) 17 (27.9%) 83
Tumor grade
 I 12 (6.6%) 5 (8.2%) 17 0.000*
 II 151 (82.5%) 31 (50.8%) 182
 III 20 (10.9%) 25 (41.0%) 45
Tumor type
 NOS 168 (91.8%) 47 (77.0%) 215 0.003*, a
 Medullary 0 (0.0%) 2 (3.3%) 2
 Undifferentiated 1 (0.5%) 0 (0.0%) 1
 Signet ring 1 (0.5%) 0 (0.0%) 1
 Mucinous 13 (7.1%) 12 (19.7%) 25

Note: aFisher’s exact test,*P<0.05.